Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
about
Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), IranRecent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinicThe Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future useDMF inhibits PDGF-BB induced airway smooth muscle cell proliferation through induction of heme-oxygenase-1.Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis.Pericytes contribute to airway remodeling in a mouse model of chronic allergic asthmaMasitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.Oxidant signaling for interleukin-13 gene expression in lung smooth muscle cellsMast cells as cellular sensors in inflammation and immunitySignal transduction and chemotaxis in mast cellsNew and developing non-adrenoreceptor small molecule drugs for the treatment of asthma.Unusual asthma syndromes and their managementMasitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.Monoclonal antibodies for the treatment of severe asthma.Identifying and testing potential new anti-asthma agents.Treatment-, patient-, and disease-related factors and the emergence of adverse events with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.Newer treatments in the management of pediatric asthma.Asthma: beyond corticosteroid treatment.Asthma therapy and its effect on airway remodelling.Masitinib for the treatment of mild to moderate Alzheimer's disease.Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?Mast cells in asthma--state of the art.Novel approaches to the management of noneosinophilic asthma.Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.Addressing corticosteroid insensitivity in adults with asthma.Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer.Designing a series of decision-theoretic phase II trials in a small population.Decrease of cocaine, but not heroin, self-administration and relapse by the tyrosine kinase inhibitor masitinib in male Sprague Dawley rats.Role of STIM1/Orai1-mediated store-operated Ca²⁺ entry in airway smooth muscle cell proliferation.Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today.Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.Safety of masitinib mesylate in healthy cats.Suppressing effects of sunitinib on allergic rhinitis: previously undefined side effects with therapeutic potential.New targets for resolution of airway remodeling in obstructive lung diseases.
P2860
Q26777154-25C939E5-E707-49BB-804A-6259920C828CQ27023557-7C7DD622-CB6C-44E4-86F3-A19F31322C56Q27025354-53E0DB04-3E72-4D11-9172-E840D547E0C3Q34273613-FD240461-9C7B-43EF-886E-E3F07BB92B7CQ34301521-A1005EC8-CE1E-4CD4-8FB1-EE126D3EC0E1Q34625206-DDD83A3F-6150-47F2-9FDF-619991FAE542Q34677487-440AE2E4-1CCF-45B1-B79D-8D4D15284837Q35275345-B9CF2ECF-653A-4B44-B67F-7F6B00DD5C87Q35579238-E834C509-F28C-4ACC-80DF-93909AEE1921Q35718193-07BCA091-DD29-4A7E-960C-DDC044A01A64Q35926109-D1C935BB-5A2A-4911-BBD5-4ADB7D43C387Q35927571-92AC833F-01F9-4080-934F-6D230C146ECDQ36240848-5D769C2B-43BA-44D0-8C9C-4454F6269A88Q36252920-63CB701E-AD97-499A-B98F-5927ADF46A32Q36443760-05CF8E57-E544-4368-B739-BDF7D519E2BFQ37637660-0257D15F-3EF1-41DC-A275-E61FD9DD73A7Q37848219-47BE3403-4F82-4413-937B-0C2CF37E8BEAQ38014555-FA3A25EA-70D4-408A-88A2-2882FA0349F5Q38095848-3F7E4BFA-FDA7-49C1-A0C0-22B7717EA536Q38113498-16AF0374-C47D-477E-95CC-DF171AF38466Q38121086-3F2AB492-2640-4E17-8DDE-5D3DE07C698EQ38233318-8763444E-517C-4978-A2C5-F8C2FE1D031FQ38472067-869EF3F7-6584-4754-A017-52C4CDAFC5B1Q38553317-596A5203-FEB8-48B0-B1C7-75C22BD4383DQ38633155-B502D872-E9E3-4066-B0A2-E5F22444A7BDQ38756064-56598547-5010-4623-ADF0-4268BE6936FBQ38882099-92E19B31-8073-470B-B9AF-2759EDC5162AQ38930984-74A1BCA7-394B-46C2-BC6B-605848D40801Q39015818-C7CB054F-FC27-4973-B768-F4CE25DA5923Q39413860-B96BA5F7-1F84-4723-B5D9-A32349AB1E6FQ41098587-C8C84060-7C5D-4B13-9E14-26501A0F1836Q47215345-AC3CC4E5-F24B-45E4-9AAB-D055E48D8B54Q52316247-FCFB2001-B257-4736-9139-7BB6DA4918F0Q53267073-8CFA98B6-4823-43D4-91D6-175B1D9353CCQ54213225-12037FF9-BB4C-448D-94D4-9A7D9650D671Q54530545-554D6BB0-C0AE-4323-A710-ECC606C4DE6DQ54582351-101C8DC1-12B4-42D1-A3F6-6AB68D0BE7D7Q54613659-1DC40A48-81E3-4E7E-BE30-924219331CD4Q54624069-5A1C6ED6-52A7-4526-A405-A85D04F11511Q55401303-5A518B30-D1FC-48A2-8D28-F9A00266839F
P2860
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Masitinib, a c-kit/PDGF recept ...... osteroid-dependent asthmatics.
@en
Masitinib, a c-kit/PDGF recept ...... osteroid-dependent asthmatics.
@nl
type
label
Masitinib, a c-kit/PDGF recept ...... osteroid-dependent asthmatics.
@en
Masitinib, a c-kit/PDGF recept ...... osteroid-dependent asthmatics.
@nl
prefLabel
Masitinib, a c-kit/PDGF recept ...... osteroid-dependent asthmatics.
@en
Masitinib, a c-kit/PDGF recept ...... osteroid-dependent asthmatics.
@nl
P2093
P50
P1433
P1476
Masitinib, a c-kit/PDGF recept ...... osteroid-dependent asthmatics.
@en
P2093
A Prud'homme
J-M Tunon-de-Lara
P304
P356
10.1111/J.1398-9995.2009.02122.X
P577
2009-08-01T00:00:00Z